

Concord Drugs Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 30 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.25 Cr
- Satisfied Charges ₹ 7.40 Cr
About Concord Drugs
Concord Drugs Limited (CDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 April 1995 and has a history of 30 years. Its registered office is in Na, Telangana.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 538965.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹18.25 Cr. The company has closed loans amounting to ₹7.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Concord Drugs Limited India are Namratha as COMPANY SECRETARY and Koni Seelam as Cfo. Sumeela Kasu, Nagavenkatahareeshkumar Solleti, Seelam Manojkumarreddy, and Three other members serve as directors at the Company.
Company Details
- Location Na, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230TG1995PLC020093
- Company No.
020093
- Stock Symbol
BSE : 538965
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
What products or services does Concord Drugs Limited offer?
Concord Drugs Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer.
Who are the key members and board of directors at Concord Drugs?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Koni Seelam ![]() | CFO | 30-Sep-2021 | Current |
Namratha ![]() | Company Secretary | 08-Apr-2024 | Current |
Nagi Seelam ![]() | Managing Director | 04-Apr-2003 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sumeela Kasu ![]() | Director | 01-Jun-2022 | Current |
Nagavenkatahareeshkumar Solleti ![]() | Director | 13-Feb-2021 | Current |
Seelam Manojkumarreddy ![]() | Whole-Time Director | 13-Aug-2021 | Current |
Ramchandra Kommula ![]() | Director | 30-Mar-2019 | Current |
Financial Performance of Concord Drugs.
Concord Drugs Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Concord Drugs?
In 2023, Concord Drugs had a promoter holding of 52.13% and a public holding of 47.87%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Cortex Laboratories Private Limited
Seelam Manojkumarreddy and Nagi Seelam are mutual person
- Proton Remedies Private Limited
Seelam Manojkumarreddy and Koni Seelam are mutual person
- Seelam Laboratories Private Limited
Seelam Manojkumarreddy is a mutual person
- Continental Pellets Pharma Private Limited
Seelam Manojkumarreddy is a mutual person
Charges (Loans)
₹18.25 Cr
₹7.40 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 18.25 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
17 Dec 2011 | State Bank Of India | ₹18.25 Cr | Open |
11 Mar 2022 | Others | ₹5.00 Cr | Satisfied |
10 Nov 2005 | Punjab National Bank | ₹1.40 Cr | Satisfied |
01 Jan 1998 | Small Industries Development Bank Of India | ₹5.00 M | Satisfied |
17 Oct 1997 | Small Industries Development Bank Of India | ₹5.00 M | Satisfied |
How Many Employees Work at Concord Drugs?
Concord Drugs has a workforce of 20 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Concord Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Concord Drugs
Recent activity within the organization
- Annual General Meeting
Concord Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with State Bank Of India of Rs. 18.25 Cr registered on 17 Dec 2011 with Charge ID 10394597 was modified on 31 Jul 2024.
- Director Appointment
Namratha was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 1 year 1 month .
- Balance Sheet
Concord Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge registered on 11 Mar 2022 via Charge ID 100568210 with Others was fully satisfied on 18 Apr 2023.
- Director Appointment
Sumeela Kasu was appointed as a Director was appointed as a Director on 01 Jun 2022 & has been associated with this company since 2 years 11 months .
Frequently asked questions
What is the Incorporation or founding date of Concord Drugs Limited?
Concord Drugs Limited was incorporated on 24 Apr 1995.
What is authorized share capital and paid-up capital of Concord Drugs Limited?
The authorized share capital of Concord Drugs Limited is ₹ 11.00 Cr and paid-up capital is ₹ 10.00 Cr.
Who are the current board members & directors of Concord Drugs Limited?
Currently 8 directors are associated with Concord Drugs Limited.
- Namratha
- Koni Reddy Seelam
- Sumeela Kasu
- Nagavenkatahareeshkumar Solleti
- Seelam Manojkumarreddy
- Koni Reddy Seelam
- Ramchandra Reddy Kommula
- Nagi Reddy Seelam
What is the registered address of Concord Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Concord Drugs Limited is Survey No.249, Brahmapally Village Hayatgar Mandal R.R.D Ist-501511 Telanga India, Na, Telangana.
What is the corporate identification number (CIN) and company number of Concord Drugs Limited?
The corporate identification number (CIN) of Concord Drugs Limited is L24230TG1995PLC020093 and the company number is 020093 as per Ministry of Corporate Affairs (MCA).
Is Concord Drugs Limited registered with any stock exchange in India?
Yes, Concord Drugs Limited is registered on Bombay Stock Exchange (BSE).
What is the official website of Concord Drugs Limited?
The Official website of Concord Drugs Limited is https://www.concorddrugs.in
How many employees does Concord Drugs Limited currently have?
As Per 2024 financial reports, 20 employees are currently employed by Concord Drugs Limited.
What are the total open charges for Concord Drugs Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Concord Drugs Limited amount to ₹ 18.25 Cr.
When was the last Balance Sheet of Concord Drugs Limited filed with the ROC?
The most recent Balance Sheet for Concord Drugs Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
TR
Thathireddy ReddyManaging DirectorCP
Chandra PanthamvarAdditional DirectorPR
Pathakota ReddyDirectorUK
Upadrasta KumarDirectorMR
Movidi RaoDirectorNR
Nallamilli ReddyManaging Director
Similar Companies Based on API Manufacturers
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Msn Laboratories Private Limited Rangareddy, Telangana, India
- Lupin Limited Mumbai, Maharashtra, India
- Ipca Laboratories Limited Mumbai, Maharashtra, India
- Divi's Laboratories Limited Rangareddy, Telangana, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India